Covidien brings on a new senior VP of corporate communications
Hologic
Hologic slips on missed Q2 revenues, lowered outlook
Bidding war for Carestream heats up | Wall Street Beat
At least 5 major private equity players are vying for medical device company Carestream Health, including Bain Capital, Carlyle Group and KKR & Co., according to Reuters.
Onex Corp. is hoping to unload Carestream, formed in the 2007 spinout of Eastman Kodak Co.’s healthcare business, for up to $3.5 billion, the news service reported.
Breast cancer: Judge stays C.R. Bard suit against Hologic over Mammosite device
Urologix names new CEO | Personnel Moves
Hologic’s fiscal Q1 profits dive on Gen-Probe acquisition costs
Hologic shuffles management teams post $4B merger with Gen-Probe | MassDevice.com On Call
MASSDEVICE ON CALL — Women’s health company Hologic (NSDQ:HOLX) announced this week former Gen-Probe chairman, president & CEO Carl Hull would step down from his new post at the merged company.
Hull manned the corner office at Gen-Probe up until Hologic acquired the company in a deal worth almost $4 billion, after which he took on a role as the senior vice president and general manager of diagnostics.
Layoffs: Hologic to shutter Indiana plant
Hologic (NSDQ:HOLX) said it plans to shutter a breast biopsy device-making plant in Indianapolis this summer, laying off all 141 workers at the facility.
The closure will roll out in 4 phases, beginning with layoffs for 20 workers March 29, according to a letter sent to the Indiana Dept. of Workforce Development from the Bedford, Mass.-based women’s health company.
Hologic hits 52-week high on mammography study | Wall Street Beat
Hologic (NSDQ:HOLX) shares hit a 52-week high yesterday on news that mammography using 3D technology significantly improved diagnostic accuracy.
HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.